{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:07:09Z","timestamp":1792480029632,"version":"4.5.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/qco.0000000000000063","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T02:33:43Z","timestamp":1398134023000},"page":"220-227","source":"Crossref","is-referenced-by-count":58,"title":["Mycoplasma pneumoniae in children"],"prefix":"10.1097","volume":"27","author":[{"given":"Patrick M.","family":"Meyer Sauteur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie M.C.","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210205","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1473-3099(01)00147-5","article-title":"Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections.","volume":"1","author":"Principi","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"R3-3-20210205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10156-010-0044-X","article-title":"Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.","volume":"16","author":"Narita","year":"2010","journal-title":"J Infect Chemother"},{"key":"R4-3-20210205","doi-asserted-by":"crossref","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study.","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med"},{"key":"R5-3-20210205","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.anai.2013.01.022","article-title":"Mycoplasma pneumoniae in children with acute and refractory asthma.","volume":"110","author":"Wood","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R6-3-20210205","first-page":"CD009175","article-title":"Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.","volume":"10","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-3-20210205","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dks457","article-title":"Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection.","volume":"68","author":"Principi","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R8-3-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.17.06.20084-en","article-title":"Mycoplasma pneumoniae: now in the focus of clinicians and epidemiologists.","volume":"17","author":"Jacobs","year":"2012","journal-title":"Euro Surveill"},{"key":"R9-3-20210205","first-page":"20072","article-title":"Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011.","volume":"17:ppii","author":"Polkowska","year":"2012","journal-title":"Euro Surveill"},{"issue":"Suppl 1","key":"R10-3-20210205","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/clinids\/17.Supplement_1.S37","article-title":"Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients.","volume":"17","author":"Foy","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R11-3-20210205","first-page":"603","article-title":"Georgia, 2012.","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R12-3-20210205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"key":"R13-3-20210205","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10096-003-1037-9","article-title":"Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents.","volume":"22","author":"Baer","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R14-3-20210205","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1086\/319981","article-title":"Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.","volume":"32","author":"Principi","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R15-3-20210205","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archpedi.156.10.1005","article-title":"Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.","volume":"156","author":"Fischer","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R16-3-20210205","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1073\/pnas.0510644103","article-title":"ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.","volume":"103","author":"Kannan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-3-20210205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s11882-013-0390-8","article-title":"Is asthma an infectious disease New evidence.","volume":"13","author":"Atkinson","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"R19-3-20210205","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/INF.0b013e3182862ea8","article-title":"Asthmatic children have increased specific anti-Mycoplasma pneumoniae IgM but not IgG or IgE-values independent of history of respiratory tract infection.","volume":"32","author":"Smith-Norowitz","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R20-3-20210205","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0000000000000063","article-title":"Comparison of Mycoplasma pneumoniae infections in asthmatic children versus asthmatic adults.","volume":"33","author":"Bebear","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R21-3-20210205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2500\/aap.2009.30.3207","article-title":"Deficient immune response to Mycoplasma pneumoniae in childhood asthma.","volume":"30","author":"Atkinson","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"R22-3-20210205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1165\/rcmb.2011-0135OC","article-title":"Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.","volume":"46","author":"Medina","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R23-3-20210205","doi-asserted-by":"crossref","first-page":"e7562","DOI":"10.1371\/journal.pone.0007562","article-title":"Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.","volume":"4","author":"Hardy","year":"2009","journal-title":"PLoS One"},{"key":"R25-3-20210205","first-page":"740","article-title":"Mycoplasma pneumoniae and mucositis--part of the Stevens-Johnson syndrome spectrum.","volume":"10","author":"Meyer Sauteur","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"R26-3-20210205","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1086\/320748","article-title":"Acute childhood encephalitis and Mycoplasma pneumoniae.","volume":"32","author":"Bitnun","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R27-3-20210205","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1469-0691.2006.01636.x","article-title":"Preceding infections and antiganglioside antibodies in patients with Guillain-Barre syndrome: a single centre prospective case-control study.","volume":"13","author":"Sinha","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"R29-3-20210205","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10096-010-0975-2","article-title":"Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.","volume":"29","author":"Loens","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R30-3-20210205","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1128\/JCM.01439-12","article-title":"Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.","volume":"50","author":"Waites","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R31-3-20210205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2012.02.014","article-title":"Optimized serodiagnosis of Mycoplasma pneumoniae infections.","volume":"73","author":"Dumke","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R32-3-20210205","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R33-3-20210205","first-page":"CD004875","article-title":"Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.","volume":"7","author":"Mulholland","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"R34-3-20210205","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"R36-3-20210205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/fmb.11.18","article-title":"Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.","volume":"6","author":"Bebear","year":"2011","journal-title":"Future Microbiol"},{"key":"R37-3-20210205","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/JCM.00678-12","article-title":"Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis.","volume":"50","author":"Liu","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R38-3-20210205","doi-asserted-by":"crossref","first-page":"e38585","DOI":"10.1371\/journal.pone.0038585","article-title":"The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel.","volume":"7","author":"Pereyre","year":"2012","journal-title":"PLoS One"},{"key":"R39-3-20210205","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jac\/dkr003","article-title":"Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children.","volume":"66","author":"Chironna","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R40-3-20210205","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1183\/09031936.00172510","article-title":"Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.","volume":"37","author":"Cardinale","year":"2011","journal-title":"Eur Respir J"},{"key":"R41-3-20210205","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/INF.0b013e3182611cee","article-title":"Management of macrolide-resistant Mycoplasma pneumoniae infection.","volume":"31","author":"Saegeman","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R42-3-20210205","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.02060-12","article-title":"Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.","volume":"57","author":"Zhao","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R43-3-20210205","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3201\/eid1908.121455","article-title":"Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.","volume":"19","author":"Hong","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R44-3-20210205","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occurred in macrolide-resistant Mycoplasma pneumoniae pneumonia.","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R45-3-20210205","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/AAC.00737-13","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.","volume":"57","author":"Miyashita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R46-3-20210205","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1128\/JCM.02840-12","article-title":"Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children.","volume":"51","author":"Cardinale","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R47-3-20210205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/1471-2334-13-591","article-title":"Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.","volume":"13","author":"Matsuda","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R48-3-20210205","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/INF.0b013e3182a25c71","article-title":"Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae associated community-acquired pneumonia in children.","volume":"32","author":"Lung","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R49-3-20210205","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R50-3-20210205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-2180-13-184","article-title":"Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs.","volume":"13","author":"Sun","year":"2013","journal-title":"BMC Microbiol"},{"key":"R51-3-20210205","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.vaccine.2009.01.135","article-title":"Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions: systematic review and meta-analysis.","volume":"27","author":"Linchevski","year":"2009","journal-title":"Vaccine"},{"key":"R52-3-20210205","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1139\/w2012-041","article-title":"Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1C DNA vaccine.","volume":"58","author":"Zhu","year":"2012","journal-title":"Can J Microbiol"},{"key":"R53-3-20210205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.micpath.2013.07.004","article-title":"Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.","volume":"64","author":"Hausner","year":"2013","journal-title":"Microb Pathog"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QCO.0000000000000063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:07:51Z","timestamp":1648865271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201406000-00003"}},"subtitle":["carriage, pathogenesis, and antibiotic resistance"],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000000063","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}